Detalhe da pesquisa
1.
Tacrolimus 0.1% versus ciclopiroxolamine 1% for maintenance therapy in patients with severe facial seborrheic dermatitis: A multicenter, double-blind, randomized controlled study.
J Am Acad Dermatol
; 84(5): 1278-1284, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33010323